Office/Laboratory Lease Sample Contracts
OFFICE/LABORATORY LEASE BETWEEN ES EAST, LLC (LANDLORD) AND BIOAGE LABS, INC. (TENANT) 5885 Hollis Street Emeryville, CaliforniaOffice/Laboratory Lease • November 7th, 2024 • BioAge Labs, Inc. • Pharmaceutical preparations • California
OFFICE/LABORATORY LEASEOffice/Laboratory Lease • October 18th, 2013 • Tetralogic Pharmaceuticals Corp • Pharmaceutical preparations • Pennsylvania
This LEASE, made this 30th day of April, 2004, by and between 335-95 Phoenixville Pike Associates a Pennsylvania Limited Partnership (hereinafter referred to as “Landlord”), and APOP Corporation. a Delaware Corporation (hereinafter referred to as “Tenant”);
FIRST AMENDMENT (5980 Horton Street, Emeryville, California)Office/Laboratory Lease • January 16th, 2024 • Kyverna Therapeutics, Inc. • Biological products, (no disgnostic substances)
OFFICE/LABORATORY LEASE BETWEEN EMERY STATION OFFICE II, LLC (LANDLORD) AND BERKELEY LIGHTS, INC. (TENANT) 5980 Horton Street Emeryville, CaliforniaOffice/Laboratory Lease • July 13th, 2020 • Berkeley Lights, Inc. • Laboratory analytical instruments • California
FIRST AMENDMENT (2929 Seventh Street, Berkeley, California)Office/Laboratory Lease • March 21st, 2022 • Caribou Biosciences, Inc. • Biological products, (no disgnostic substances)
This First Amendment (this “Amendment”), dated as of January II, 2022, is entered into by and between 2929 SEVENTH ST., LLC, a California limited liability company (“Landlord”), and CARIBOU BIOSCIENCES, INC., a Delaware corporation (“Tenant”).
ContractOffice/Laboratory Lease • November 23rd, 2015 • Aduro Biotech, Inc. • Pharmaceutical preparations • California
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
ContractOffice/Laboratory Lease • November 6th, 2025 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
Certain information (identified by “[***]”) has been excluded from the exhibit pursuant to Item 601(b)(10) because it is both (i) not material and (ii) is of the type that the registrant treats as private and confidential.